Cytokinetics Stock (NASDAQ:CYTK), Quotes and News Summary

Q: What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.

Open	$66.880
Close	$67.550
Volume / Avg.	1.607M / 2.115M
Day Range	64.815 - 67.800
52 Wk Range	25.980 - 110.250
Market Cap	$7.111B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	20.7%
Days to Cover	6.59

Recent News

Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Monday. Shares of Banco Santander, S.A. (NYSE: SAN) shares fell sharply during today’s pre-market trading.

Avi Kapoor

Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst

Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed as a distinctive therapy for Hypertrophic Cardiomyopathy.

Vandana Singh

Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition

Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cytokinetics Inc

Sector

Health Care

Industry

Biotechnology

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for disea...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cytokinetics (CYTK) stock?

You can purchase shares of Cytokinetics (NASDAQ: CYTK) through any online brokerage.

View our list of the best stock brokerages.

Who are Cytokinetics's (CYTK) competitors?

Other companies in Cytokinetics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for Cytokinetics (CYTK) stock?

The latest price target for Cytokinetics (NASDAQ: CYTK) was reported by Needham on Tuesday, April 9, 2024. The analyst firm set a price target for 108.00 expecting CYTK to rise to within 12 months (a possible 58.82% upside). 34 analyst firms have reported ratings in the last year.

Current Stock Price for Cytokinetics (CYTK)?

The stock price for Cytokinetics (NASDAQ: CYTK) is $68 last updated Today at April 19, 2024 at 4:39 PM EDT.

Does Cytokinetics (CYTK) pay a dividend?

There are no upcoming dividends for Cytokinetics.

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

Cytokinetics’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Cytokinetics (CYTK) going to split?

There is no upcoming split for Cytokinetics.

What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-